1. Repository of OAI
Ελληνικά   English  
Saved Searches

Discover

Search


Current filters:

Clear current filters  or Add more filters

View Option


Results 1-10 of 16 (Search time: 0.004 seconds).

  Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia (Journal article)

  Lipoprotein (a), apolipoprotein (a) phenotypes, and thyroid autoimmunity in uremic patients (Journal article)

  Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia (Journal article)

  Increased activity of PAF-acetylhydrolase in low density lipoprotein subfractions induces enhanced lysophosphatidylcholine production in patients with heterozygous familial hypercholesterolemia (Journal article)

  Lipoprotein (a), apolipoprotein (a), phenotype and thyroid autoimmunity in patients with renal failure (Journal article)

  Lipid parameters including Lp(a) in hemodialysis patients (Journal article)

  Lp(a) levels in patients with mild/moderate renal failure (Journal article)

  Lp(a) levels are different in patients with various types of primary hyperlipidemia (Journal article)

  Current methodologies for the estimation of LDL-cholesterol in hemodialysis patients, based on homogeneous HDL-C, homogeneous LDL-C, immunoseparation LDL-C and ApoB assays (Journal article)

  Long-term treatment with EPO increases serum levels of high-density lipoprotein in patients with CKD (Journal article)